Back
OncoCyte Stock Price Chart
Sponsored
OCX
Sponsored
America's Final Republican President
Click here to see his 2024 election prediction.
Sell
28
OCX
OncoCyte
Last Price:
2.76
Seasonality Move:
-19.6%
7 Day Trial
ALL ACCESS PASS
$
7
MarketBeat Alert: Strong sell signal just issued for these 20 stocks
Go here now to get free instant access to all 20 stocks to sell.- The current trend is relatively stagnant and OCX is experiencing buying pressure, which is a positive indicator for future bullish movement.
OncoCyte Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.49 | Buy |
20-day SMA: | 2.66 | Sell |
50-day SMA: | 2.86 | Sell |
200-day SMA: | 3.17 | Sell |
8-day EMA: | 2.53 | Buy |
20-day EMA: | 2.63 | Sell |
50-day EMA: | 2.8 | Sell |
200-day EMA: | 3.89 | Sell |
OncoCyte Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.12 | Sell |
Relative Strength Index (14 RSI): | 42.29 | Sell |
Chaikin Money Flow: | 4589 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.52 - 2.92) | Sell |
Bollinger Bands (100): | (2.69 - 3.23) | Sell |
OncoCyte Technical Analysis
Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for OncoCyte Stock
Is OncoCyte Stock a Buy?
- OncoCyte share price is 2.57 while OCX 8-day simple moving average is 2.49, which is a Buy signal.
- The stock price of OCX is 2.57 while OncoCyte 20-day SMA is 2.66, which makes it a Sell.
- OncoCyte 50-day simple moving average is 2.86 while OCX share price is 2.57, making it a Sell technically.
- OCX stock price is 2.57 and OncoCyte 200-day simple moving average is 3.17, creating a Sell signal.
OCX Technical Analysis vs Fundamental Analysis
OncoCyte Stock Info
Market Cap:
34.28M
Price in USD:
2.57
Share Volume:
4.59K
OncoCyte 52-Week Range
52-Week High:
5.88
52-Week Low:
2.08
Sell
28
OncoCyte (OCX)
is a Sell
OncoCyte Share Price Forecast
-
What is the OncoCyte stock price today?
The OncoCyte stock price is 2.57 USD today. -
Will OCX stock go up or go down?
OncoCyte> share price is forecast to RISE/FALL based on technical indicators -
Is OncoCyte overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, OncoCyte is overvalued.
Is OncoCyte Stock a Buy?
- OncoCyte share price is 2.57 while OCX 8-day exponential moving average is 2.53, which is a Buy signal.
- The stock price of OCX is 2.57 while OncoCyte 20-day EMA is 2.63, which makes it a Sell.
- OncoCyte 50-day exponential moving average is 2.80 while OCX share price is 2.57, making it a Sell technically.
- OCX stock price is 2.57 and OncoCyte 200-day simple moving average is 3.89, creating a Sell signal.
Fundamental Analysis of OncoCyte
Is OncoCyte a good investment?
- Analysts estimate an earnings decrease this quarter of $0.43 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.17 per share, and an increase next year of $0.68 per share.
Technical Analysis of OncoCyte
Should I short OncoCyte stock?
- OCX Moving Average Covergence Divergence (MACD) indicator is -0.12, suggesting OncoCyte is a Sell
- OncoCyte Relative Strength Index (RSI) is 42.29, which suggest OncoCyte is oversold
- The Bollinger Bands (25) for OncoCyte is (2.52 - 2.92), which suggest OncoCyte is a Sell
- The Bollinger Bands (100) for OncoCyte is (2.69 - 3.23), which suggest OncoCyte is a Sell
* OncoCyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.